The burden and risks of emerging complications of diabetes mellitus

D Tomic, JE Shaw, DJ Magliano - Nature Reviews Endocrinology, 2022 - nature.com
The traditional complications of diabetes mellitus are well known and continue to pose a
considerable burden on millions of people living with diabetes mellitus. However, advances …

COVID-19: Immunology and treatment options

S Felsenstein, JA Herbert, PS McNamara… - Clinical …, 2020 - Elsevier
The novel coronavirus SARS-CoV2 causes COVID-19, a pandemic threatening millions. As
protective immunity does not exist in humans and the virus is capable of escaping innate …

[HTML][HTML] Why does COVID-19 disproportionately affect older people?

AL Mueller, MS McNamara, DA Sinclair - Aging (albany NY), 2020 - ncbi.nlm.nih.gov
The severity and outcome of coronavirus disease 2019 (COVID-19) largely depends on a
patient's age. Adults over 65 years of age represent 80% of hospitalizations and have a 23 …

Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis

A Kumar, A Arora, P Sharma, SA Anikhindi… - Diabetes & Metabolic …, 2020 - Elsevier
Background Many studies on COVID-19 have reported diabetes to be associated with
severe disease and mortality, however, the data is conflicting. The objectives of this meta …

[HTML][HTML] Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis

Y Zhou, Q Yang, J Chi, B Dong, W Lv, L Shen… - International Journal of …, 2020 - Elsevier
Objectives Existing findings regarding the relationship between comorbidities and the
severity of coronavirus disease 2019 (COVID-19) are inconsistent and insufficient. The aim …

Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities

LA Bienvenu, J Noonan, X Wang… - Cardiovascular …, 2020 - academic.oup.com
The high mortality rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
infection is a critical concern of the coronavirus disease 2019 (COVID-19) pandemic …

Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension …

P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie… - Circulation …, 2020 - Am Heart Assoc
Rationale: Use of ACEIs (angiotensin-converting enzyme inhibitors) and ARBs (angiotensin
II receptor blockers) is a major concern for clinicians treating coronavirus disease 2019 …

[HTML][HTML] Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review …

X Wang, X Fang, Z Cai, X Wu, X Gao, J Min, F Wang - Research, 2020 - spj.science.org
The recent outbreak of COVID-19 has been rapidly spreading on a global scale. To date,
there is no specific vaccine against the causative virus, SARS-CoV-2, nor is there an …

Potential effects of coronaviruses on the cardiovascular system: a review

M Madjid, P Safavi-Naeini, SD Solomon… - JAMA …, 2020 - jamanetwork.com
Importance Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes
coronavirus disease 2019 (COVID-19) has reached a pandemic level. Coronaviruses are …

Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China

J Xu, X Yang, L Yang, X Zou, Y Wang, Y Wu, T Zhou… - Critical Care, 2020 - Springer
Background The global numbers of confirmed cases and deceased critically ill patients with
COVID-19 are increasing. However, the clinical course, and the 60-day mortality and its …